Manufacturer record
Vintochem Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Vintochem Pharmaceuticals (Madhya Pradesh) were declared Not of Standard Quality between May 2019 and January 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CV-212, Calcium with Vitamin D3 Tablets (exp May 2022). RDTL Guwahati (state lab) found it not of standard quality: Dissolution. Listed in the January 2022 alert.
Records by type
3 records linked to Vintochem Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Calcium with Vitamin D3 Tablets | Batch CV-212Mfg Nov 2020 · Exp May 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2022 |
| Calcium with Vitamin D3 Tablets | Batch CV-212Mfg Nov 2020 · Exp May 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2022 |
| Chlorpheniramine Maleate Tablets IP 4 mg (CPM) | Batch 12-1904Mfg Nov 2018 · Exp Oct 2020 | Related SubstancesRelated substances | CDTL MumbaiCDSCO lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.